SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 227 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $516,937 | -67.3% | 18,750 | -57.0% | 0.01% | -68.8% |
| Q1 2023 | $1,580,316 | +1.1% | 43,619 | -0.4% | 0.02% | 0.0% |
| Q4 2022 | $1,562,453 | +3.2% | 43,803 | -2.1% | 0.02% | -5.9% |
| Q3 2022 | $1,514,000 | +16.6% | 44,735 | -0.3% | 0.02% | +30.8% |
| Q2 2022 | $1,298,000 | -25.4% | 44,891 | -16.6% | 0.01% | -13.3% |
| Q1 2022 | $1,739,000 | -76.9% | 53,810 | -79.2% | 0.02% | -73.2% |
| Q4 2021 | $7,527,000 | -24.0% | 258,124 | -30.5% | 0.06% | -24.3% |
| Q3 2021 | $9,903,000 | -12.3% | 371,325 | +1.2% | 0.07% | -5.1% |
| Q2 2021 | $11,297,000 | +14.6% | 366,895 | -2.5% | 0.08% | +18.2% |
| Q1 2021 | $9,854,000 | +1.1% | 376,399 | -2.8% | 0.07% | -18.5% |
| Q4 2020 | $9,743,000 | +56.8% | 387,231 | +29.9% | 0.08% | +20.9% |
| Q3 2020 | $6,214,000 | +5.9% | 298,178 | +20.7% | 0.07% | +3.1% |
| Q2 2020 | $5,867,000 | +40.0% | 247,029 | +6.0% | 0.06% | +14.0% |
| Q1 2020 | $4,192,000 | -29.2% | 233,002 | -6.6% | 0.06% | +7.5% |
| Q4 2019 | $5,918,000 | -0.9% | 249,502 | +14.8% | 0.05% | -3.6% |
| Q3 2019 | $5,974,000 | +1168.4% | 217,409 | +1428.9% | 0.06% | +1275.0% |
| Q2 2019 | $471,000 | +70.0% | 14,220 | +80.0% | 0.00% | +100.0% |
| Q1 2019 | $277,000 | -92.0% | 7,902 | -86.4% | 0.00% | -91.7% |
| Q2 2018 | $3,471,000 | +13.1% | 58,000 | -13.4% | 0.02% | +14.3% |
| Q1 2018 | $3,069,000 | -22.2% | 67,000 | -32.3% | 0.02% | -19.2% |
| Q4 2017 | $3,945,000 | -38.0% | 99,000 | -37.7% | 0.03% | -38.1% |
| Q3 2017 | $6,360,000 | -7.2% | 159,000 | 0.0% | 0.04% | -6.7% |
| Q2 2017 | $6,853,000 | +68.4% | 159,000 | +22.3% | 0.04% | +66.7% |
| Q1 2017 | $4,069,000 | – | 130,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 335,000 | $8,934,000 | 13.38% |
| ASHFORD CAPITAL MANAGEMENT INC | 1,016,665 | $27,114,000 | 2.46% |
| Bruce & Co., Inc. | 402,105 | $10,724,000 | 2.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 297,500 | $7,934,000 | 1.91% |
| ARMISTICE CAPITAL, LLC | 3,900,000 | $104,013,000 | 1.76% |
| Bridge City Capital, LLC | 108,884 | $2,904,000 | 1.32% |
| S&T BANK/PA | 316,098 | $8,430,000 | 1.31% |
| Kent Lake Capital LLC | 100,000 | $2,667,000 | 1.15% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 331,140 | $8,832,000 | 1.02% |
| Prairiewood Capital, LLC | 45,297 | $1,208,000 | 0.99% |